Condition
Muscular Fatigue
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 77/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Completed3
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05217433Not ApplicableCompletedPrimary
Oleuropein and Muscle Energy Metabolism
NCT04441840Not ApplicableCompleted
Immune and Recovery Modulating Impact of Probiotic Supplementation After Intense Resistance Exercise
NCT03902730Not ApplicableCompleted
Leg Muscle Activity Measured Via Electromyography in Back Squat Variations
NCT00785811Phase 4TerminatedPrimary
Effect of Chronic Supplementation of L-arginine in the Muscular Performance
Showing all 4 trials